Telomir Pharmaceuticals (TELO) Cash & Equivalents (2022 - 2026)
Telomir Pharmaceuticals (TELO) reported Cash & Equivalents of $5.2 million for Q2 2026, up 589.4% from $754,323 a year earlier.
Powered by 
Analysis
Telomir Pharmaceuticals (TELO) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Telomir Pharmaceuticals posted Cash & Equivalents of $7.29 million, up 475.5% from FY2024.
- Cash & Equivalents has a three-year compound annual growth rate of 1625.2% (FY2022 to FY2025).
- By year, Cash & Equivalents came in at $1.27 million in FY2024, $1,231 in FY2023 (-13.2%) and $1,419 in FY2022.
- Five-year quarterly Cash & Equivalents spans a low of $1,231 in Q4 2023 and a high of $7.33 million in Q3 2025.
- Year over year, Cash & Equivalents gained in three of the last five quarters, with growth averaging 339.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Telomir Pharmaceuticals | 82.53 Mn | 82.53 Mn | - | 5.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.20 Mn |
| Dec 31, 2025 | 7.29 Mn |
| Sep 30, 2025 | 7.33 Mn |
| Jun 30, 2025 | 754,323.00 |
| Mar 31, 2025 | 402,999.00 |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 834,638.00 |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | 1,231.00 |
| Sep 30, 2023 | 2,452.00 |
| Jun 30, 2023 | 14,629.00 |
| Mar 31, 2023 | 1,807.00 |
| Dec 31, 2022 | 1,419.00 |
API Access
Telomir Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TELO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TELO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TELO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();